Human Recombinant IFN-A 2A (from E. coli)

Supplier: SHENANDOAH BIOTECHNOLOGY

100-54-100UG 100-54-1MG 100-54-20UG 100-54-250UG 100-54-500UG
SHBT100-54-100UGEA 181 EUR
SHBT100-54-100UG SHBT100-54-1MG SHBT100-54-20UG SHBT100-54-250UG SHBT100-54-500UG
Human Recombinant IFN-A 2A (from E. coli)
Proteins and Peptides

Interferon-alpha 2a (IFN-α 2a) is a type I interferon made by leukocytes during viral infection. The JAK-STAT pathway mediates the antiviral and anti-cell proliferation activities of IFN-α 2a. IFN-α proteins are widely used as standard treatments during antiviral and antineoplastic therapies. The IFN-α 2a variant differs from IFN-α 2b by one amino acid.


  • High quality
  • Low endotoxin
  • Affordable


Caution: For research use only.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR